Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class - Effective August 22, 2024

Date: August 26, 2024
Attention: Providers
Effective date: August 22, 2024

Call to action: Effective August 22, 2024, Fluticasone Prop Diskus will now be preferred along with brand Flovent Diskus. This is in response to discontinuation of brand product Flovent Diskus by the manufacturer. 

The preferred status of the brand name Flovent Diskus will not change to allow any remaining stock to be used.

How this impacts providers: The change will allow providers to prescribe the generic without requiring Preferred Drug List (PDL) prior authorization at this time and continue accessing necessary medication for their patients. 

Next step for Providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.

If you have any questions, please email TCHP Pharmacy at: tchppharmacy@texaschildrens.org. 

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.